Assignee
CONSTELLATION PHARMACEUTICALS INC
US·33 granted patents·30 pending applications·151 citations·filing 2012–2024
Top patents by PatentIndex Score
63 records- 0197US9469646B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Oct 18, 2016·21 cites·4 claims
- 0296US9409865B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Aug 9, 2016·14 cites·3 claims
- 0393US9085583B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION—PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·18 cites·14 claims
- 0492US9051269B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Jun 9, 2015·9 cites·7 claims
- 0591US9969747B2Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamideCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted May 15, 2018·12 cites·13 claims
- 0691US9371331B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·8 cites·9 claims
- 0791US9206128B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·10 cites·17 claims
- 0890US10918646B1Methods of treating myeloproliferative disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·30 claims
- 0990US10689371B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·5 cites·29 claims
- 1090US9624244B2Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Apr 18, 2017·8 cites·6 claims
- 1188US11274095B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Granted Mar 15, 2022·2 cites·34 claims
- 1287US9745305B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·11 cites·17 claims
- 1387US9522920B2Bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Dec 20, 2016·10 cites·21 claims
- 1486US10016405B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jul 10, 2018·3 cites·4 claims
- 1585US9980952B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·8 claims
- 1685US9969716B2Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted May 15, 2018·4 cites·21 claims
- 1782US11919912B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 5, 2024·2 cites·18 claims
- 1880US10526287B2LSD1 inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jan 7, 2020·2 cites·22 claims
- 1978US10517849B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Dec 31, 2019·2 cites·23 claims
- 2076US11013718B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·18 claims
- 2175US2025230137A1P300/cbp hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2274US2024116905A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2373US9925197B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·1 cites·5 claims
- 2473US2025136588A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2572US9493483B2Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·1 cites·8 claims
- 2670US11547695B2LSD1 inhibitors and medical uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Granted Jan 10, 2023·0 cites·19 claims
- 2769USRE47428EModulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Jun 11, 2019·0 cites·4 claims
- 2868US12070464B2Methods of treating myeloproliferative disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2022·Granted Aug 27, 2024·0 cites·17 claims
- 2968US10035801B2Pyrazolo compounds and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Jul 31, 2018·1 cites·15 claims
- 3066US2019125737A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3164US2015376190A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3264US2025122217A1Anhydrous crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamideCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3361US2024269146A1Use of pelabresib for treating anemiasCONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3460US12172990B2Modulators of TREX1CONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·19 claims
- 3560US11274090B2P300/CBP HAT inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·0 cites·24 claims
- 3657US2024246946A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3757US2026021082A1Ezh2 inhibition therapies for the treatment of at-rich interactive domain-containing protein 1a (arid1a) mutated cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3856US2024262814A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3955US2023414593A1Ezh2 inhibition therapies for the treatment of androgen receptor mutated prostate cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4053US11459315B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Oct 4, 2022·0 cites·11 claims
- 4152US10457640B2Synthesis of inhibitors of EZH2CONSTELLATION PHARMACEUTICALS INC·Filed 2017·Granted Oct 29, 2019·0 cites·20 claims
- 4252US2019048048A1Fusion proteins and methods for identifying bromodomain inhibiting compoundsCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4352US2022135538A1P300/cbp hat inhibitors and methods for their useCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4451US2022331304A1Compounds for use in treating neurological disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4551US2022257577A1Ezh2 inhibition in combination therapies for the treatment of cancersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4651US2022313701A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4750US2023302010A12-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide for treating thrombocythemiaCONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4850US2022289728A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4948US11414384B2P300/CBP hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 5048US2023233541A1Substituted benzamides as modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →